Innovent Biologics Inc. (IVBXF)

PNK: IVBXF · Real-Time Price · USD

5.97

0.00 (0.00%)

At close: Apr 29, 2025, 8:00 PM

Innovent Biologics Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	10.05B	1.02B	1.36B	1.28B	2.43B	4.53B	510.47M	1.01B
Short-Term Investments	917.53M	7.25B	6.58B	6.77B	2.27B	82.32M	809.48M	782.25M
Long-Term Investments	794.09M	713.22M	-6.16B	-6.76B	-2.27B	n/a	n/a	n/a
Other Long-Term Assets	1.72B	110.04M	6.71B	6.91B	2.52B	250.31M	135.53M	100.88M
Receivables	1.01B	575.27M	968.4M	475.38M	250.04M	7.5M	n/a	n/a
Inventory	968.09M	1.43B	1.35B	705.66M	358.6M	66.12M	57.72M	36.63M
Other Current Assets	484.38M	336.52M	219.9M	164.51M	151.63M	14.97M	68.08M	38.88M
Total Current Assets	13.43B	11.51B	11.55B	9.47B	5.46B	4.69B	1.45B	1.87B
Property-Plant & Equipment	4.66B	4.06B	3.38B	2.18B	1.52B	1.12B	821.84M	788.84M
Goodwill & Intangibles	27.79M	1.2B	772.19M	32.63M	n/a	52.84M	54.09M	55.34M
Total Long-Term Assets	7.2B	6.08B	4.69B	2.37B	1.78B	1.43B	1.01B	945.05M
Total Assets	20.63B	17.59B	16.24B	11.83B	7.23B	6.11B	2.46B	2.82B
Account Payables	372.55M	325.62M	195.05M	120.62M	84.28M	42.82M	34.84M	21.2M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-96.85M	-30.78M	n/a
Short-Term Debt	1.2B	888M	365M	255M	17M	10M	5M	n/a
Other Current Liabilities	728.33M	741.92M	790.15M	274.13M	144.26M	98.43M	18.03M	26.39M
Total Current Liabilities	4.48B	3.5B	3.05B	1.49B	1.04B	670.32M	163.28M	76.2M
Long-Term Debt	2.33B	2.22B	2.02B	925.18M	808M	782M	505M	500M
Other Long-Term Liabilities	1.22B	1.05B	753.62M	n/a	n/a	n/a	371.19M	311.79M
Total Long-Term Liabilities	3.62B	3.36B	2.86B	1.57B	1.43B	1.25B	3.92B	3.7B
Total Liabilities	8.1B	6.86B	5.91B	3.06B	2.47B	1.92B	4.08B	3.77B
Total Debt	3.62B	3.23B	2.5B	1.21B	865.09M	792M	510M	500M
Common Stock	112K	105K	101K	97K	87K	79K	8K	6K
Retained Earnings	-15.77B	-16.68B	-12.56B	-9.98B	-8.98B	-8.27B	-1.79B	-1.04B
Comprehensive Income	n/a	763.86M	397.02M	220.41M	-145.65M	-293.29M	-504.64M	-465.06M
Shareholders Equity	12.53B	10.73B	10.33B	8.78B	4.76B	4.19B	-1.94B	-1.38B
Total Investments	794.09M	630.2M	417.25M	12.94M	1.98M	82.32M	809.48M	782.25M